British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 84-85 , March 2010

“Paraplegia as a complication of intravesical Botulinum toxin A (Dysport®) injection for overactive bladder” by Awsare and Jones [Br. J. Med. Surg. Urol. 2 (2009) 127–128]

Received 18 September 2009

References 

  1. Wiegand H, Erdmann G, Wellhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):161–165
  2. Tang-Liu DD, et al. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon. 2003;42(5):461–469
  3. Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004;20(7):981–990
  4. Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ, Giannantoni A, et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol. 2008;[Epub ahead of print]

PII: S1875-9742(09)00156-6

doi: 10.1016/j.bjmsu.2009.09.024

British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 84-85 , March 2010

Article Tools